NO-donor phenols: A new class of products endowed with antioxidant and vasodilator properties

被引:52
作者
Boschi, Donatella
Tron, Gian Cesare
Lazzarato, Loretta
Chegaev, Konstantin
Cena, Clara
Di Stilo, Antonella
Giorgis, Marta
Bertinaria, Massimo
Fruttero, Roberta
Gasco, Alberto
机构
[1] Univ Turin, Dipartimento Sci & Tecnol Farmaco, I-10125 Turin, Italy
[2] Univ Piemonte Orientale, Dipartimento Sci Chim Alimentari Farmaceut & Farm, I-28100 Novara, Italy
关键词
D O I
10.1021/jm0510530
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The synthesis and study of the antioxidant and vasodilator properties of a new class of phenols able to release nitric oxide are described. The products were designed through a symbiotic approach using selected phenols and selected nitrooxy and furoxan NO-donors as reference models. The antioxidant activities of the hybrid products were assessed by detecting the 2-thiobarbituric acid reactive substances (TBARS) produced in the ferrous salt/ascorbate-induced autoxidation of lipids present in microsomial membranes of rat hepatocytes. The vasodilator activity was assessed on rat aortic strips precontracted with phenylephrine. Some of the products (13, 35, 37, 60-62, 64) behave principally as vasodilators and others as antioxidants (24, 32, 72), and the two properties are relatively balanced in 19, 41, and 68. Further in vivo studies should clarify whether some of these products may become preclinical candidates for the treatment of cardiovascular disease underpinned by atheroma.
引用
收藏
页码:2886 / 2897
页数:12
相关论文
共 31 条
[1]   Structure-property relationships of trimetazidine derivatives and model compounds as potential antioxidants [J].
Ancerewicz, J ;
Migliavacca, E ;
Carrupt, PA ;
Testa, B ;
Brée, F ;
Zini, R ;
Tillement, JP ;
Labidalle, S ;
Guyot, D ;
Chauvet-Monges, AM ;
Crevat, A ;
Le Ridant, A .
FREE RADICAL BIOLOGY AND MEDICINE, 1998, 25 (01) :113-120
[2]  
[Anonymous], HARRISONS PRINCIPLES
[3]  
Antolovich M, 2002, ANALYST, V127, P183, DOI 10.1039/b009171p
[4]   Design and synthesis of analogs of vitamin E: Antiproliferative activity against human breast adenocarcinoma cells [J].
Arya, P ;
Alibhai, N ;
Qin, H ;
Burton, GW ;
Batist, G ;
You, SXL ;
Alaoui-Jamali, MA .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1998, 8 (18) :2433-2438
[5]  
Biswas S. K., 2005, BIOCHEM BIOPH RES CO, V338, P1
[6]   CARDIOVASCULAR ACTIONS OF THE FUROXAN CAS-1609, A NOVEL NITRIC-OXIDE DONOR [J].
BOHN, H ;
BRENDEL, J ;
MARTORANA, PA ;
SCHONAFINGER, K .
BRITISH JOURNAL OF PHARMACOLOGY, 1995, 114 (08) :1605-1612
[7]   Development of a new class of potential antiatherosclerosis agents: NO-donor antioxidants [J].
Cena, C ;
Boschi, D ;
Tron, GC ;
Chegaev, K ;
Lazzarato, L ;
Di Stilo, A ;
Aragno, M ;
Fruttero, R ;
Gasco, A .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (24) :5971-5974
[8]   Cardiovascular hybrid drugs: Combination of more than one pharmacological property in one single molecule [J].
Christiaans, JAM ;
Timmerman, H .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 1996, 4 (01) :1-22
[9]   The involvement of the release of nitric oxide in the pharmacological activity of the new furoxan derivative CHF 2363 [J].
Civelli, M ;
Giossi, M ;
Caruso, P ;
Razzetti, R ;
Bergamaschi, M ;
Bongrani, S ;
Gasco, A .
BRITISH JOURNAL OF PHARMACOLOGY, 1996, 118 (04) :923-928
[10]   New 1,4-dihydropyridines conjugated to furoxanyl moieties, endowed with both nitric oxide-like and calcium channel antagonist vasodilator activities [J].
Di Stilo, A ;
Visentin, S ;
Cena, C ;
Gasco, AM ;
Ermondi, G ;
Gasco, A .
JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (27) :5393-5401